About NuView Life Sciences
NuView Life Sciences is a company based in Park City (United States) founded in 2005.. NuView Life Sciences has raised $90 million across 3 funding rounds from investors including HHS and Global Emerging Markets. NuView Life Sciences offers products and services including NV-VPAC1, In Vitro Diagnostic Kit, and PET Imaging Agent. NuView Life Sciences operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Park City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nuview Life Sciences, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$90 M (USD)
in 3 rounds
-
Latest Funding Round
$90 M (USD), Private Equity Round
Aug 03, 2020
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuView Life Sciences
NuView Life Sciences offers a comprehensive portfolio of products and services, including NV-VPAC1, In Vitro Diagnostic Kit, and PET Imaging Agent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Proprietary molecule for cancer imaging and targeted therapy applications.
Detects cancer cells in biofluids without invasive procedures.
Uses Copper-64 for in vivo cancer diagnosis and localization.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of NuView Life Sciences
NuView Life Sciences has successfully raised a total of $90M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $90 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Private Equity Round — $90.0M
-
First Round
First Round
(18 Aug 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Private Equity Round - NuView Life Sciences | Valuation | Global Emerging Markets |
|
| Sep, 2011 | Amount | Grant - NuView Life Sciences | Valuation |
investors |
|
| Aug, 2011 | Amount | Grant - NuView Life Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NuView Life Sciences
NuView Life Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Global Emerging Markets. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NuView Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NuView Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nuview Life Sciences Comparisons
Competitors of NuView Life Sciences
NuView Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nuview Life Sciences
Frequently Asked Questions about NuView Life Sciences
When was NuView Life Sciences founded?
NuView Life Sciences was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Where is NuView Life Sciences located?
NuView Life Sciences is headquartered in Park City, United States. It is registered at Park City, Utah, United States.
Who is the current CEO of NuView Life Sciences?
Paul Crowe is the current CEO of NuView Life Sciences.
Is NuView Life Sciences a funded company?
NuView Life Sciences is a funded company, having raised a total of $90M across 3 funding rounds to date. The company's 1st funding round was a Grant of $182.97K, raised on Aug 18, 2011.
What does NuView Life Sciences do?
NuView Life Sciences was founded in 2005 and is based in Park City, United States. Operations focus on the biotechnology sector, where a diagnostic device known as NV-VPAC1 is developed. This device utilizes peptide analogs to target the vasoactive intestinal peptide receptor type 1 (VPAC1), which is overexpressed in malignancies including breast, prostate, colon, bladder, and endometrial cancers. Diagnostic services for these conditions are thereby supported.
Who are the top competitors of NuView Life Sciences?
NuView Life Sciences's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does NuView Life Sciences offer?
NuView Life Sciences offers NV-VPAC1, In Vitro Diagnostic Kit, and PET Imaging Agent.
Who are NuView Life Sciences's investors?
NuView Life Sciences has 2 investors. Key investors include HHS, and Global Emerging Markets.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.